Plasma Levels of mir-34a-5p Correlate with Systemic Inflammation and Low Naïve CD4 T Cells in Common Variable ImmunodeficiencyShow others and affiliations
2024 (English)In: Journal of Clinical Immunology, ISSN 0271-9142, E-ISSN 1573-2592, Vol. 44, no 1, article id 21Article in journal (Refereed) Published
Abstract [en]
PurposeCommon variable immunodeficiency (CVID) is a primary antibody deficiency that commonly manifests as recurrent infections. Many CVID patients also suffer from immune dysregulation, an inflammatory condition characterized by polyclonal lymphocytic tissue infiltration and associated with increased morbidity and mortality. The genetic cause is unknown in most CVID patients and epigenetic alterations may contribute to the broad range of clinical manifestations. MicroRNAs are small non-coding RNAs that are involved in epigenetic modulation and may contribute to the clinical phenotype in CVID.MethodsHere, we determined the circulating microRNAome and plasma inflammatory proteins of a cohort of CVID patients with various levels of immune dysregulation and compared them to healthy controls. A set of deregulated microRNAs was validated by qPCR and correlated to inflammatory proteins and clinical findings.ResultsLevels of microRNA-34a correlated with 11 proteins such as CXCL9, TNF, and IL10, which were predicted to be biologically connected. Moreover, there was a negative correlation between mir-34 levels and the number of naive CD4 T cells in CVID.ConclusionCollectively, our data show that microRNAs correlate with the inflammatory response in CVID. Further investigations are needed to elucidate the role of miRNAs in the development of CVID-related immune dysregulation.
Place, publisher, year, edition, pages
SPRINGER/PLENUM PUBLISHERS , 2024. Vol. 44, no 1, article id 21
Keywords [en]
Inborn errors of immunity; common variable immunodeficiency; immune dysregulation; circulating miRNAs; next generation sequencing
National Category
Rheumatology and Autoimmunity
Identifiers
URN: urn:nbn:se:liu:diva-200248DOI: 10.1007/s10875-023-01618-0ISI: 001127428300014PubMedID: 38129593OAI: oai:DiVA.org:liu-200248DiVA, id: diva2:1829444
Note
Funding Agencies|Linkoping University; ALF Region Ostergoetland, Sweden [ROE-96962]; Bertil and Ebon Norlin's Foundation for medical research, Sweden [1203]
2024-01-192024-01-192024-11-22